Published in J Neuropathol Exp Neurol on July 01, 1991
Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol (1992) 1.04
Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry (1995) 0.90
Basophilic inclusions in sporadic juvenile amyotrophic lateral sclerosis: an immunocytochemical and ultrastructural study. Acta Neuropathol (1992) 0.85
Immunocytochemical and ultrastructural studies of the motor cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1994) 0.82
Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1992) 0.82
Comparative study of spinal cord ubiquitin expression in post-poliomyelitis and sporadic amyotrophic lateral sclerosis. Acta Neuropathol (1994) 0.81
Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis. Mol Med (1998) 0.79
Expression and cellular distribution of ubiquitin in response to injury in the developing spinal cord of Monodelphis domestica. PLoS One (2013) 0.76
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem (1995) 3.20
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci U S A (1985) 2.86
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology (2002) 2.34
Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer (1980) 2.26
In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein. Biochem Biophys Res Commun (1986) 2.16
Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain (2001) 2.14
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol (1989) 2.07
Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. Neuron (2000) 2.04
Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci U S A (1988) 2.04
A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol (1999) 1.98
Presenilin-1 mutations in Alzheimer's disease. Nature (2000) 1.97
Dysembryoplastic neuroepithelial tumour of the cerebellum. Acta Neuropathol (1995) 1.95
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J Biol Chem (1997) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem (1999) 1.83
Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery (1989) 1.82
Typing prion isoforms. Nature (1997) 1.82
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol (1980) 1.78
A distinct MR imaging phenotype in amyotrophic lateral sclerosis: correlation between T1 magnetization transfer contrast hyperintensity along the corticospinal tract and diffusion tensor imaging analysis. AJNR Am J Neuroradiol (2011) 1.77
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med (1986) 1.73
Neurofibrillary changes in human brain. An immunocytochemical study with a neurofilament antiserum. J Neuropathol Exp Neurol (1983) 1.72
Medullomyoblastoma: report of two cases. Childs Nerv Syst (1992) 1.70
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. J Neurol Neurosurg Psychiatry (2002) 1.64
Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61
Hydrocephalus, lissencephaly, ocular abnormalities and congenital muscular dystrophy. A Warburg syndrome variant? Neuropediatrics (1986) 1.61
Bodian's silver method stains neurofilament polypeptides. Science (1981) 1.59
Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol (1998) 1.56
Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry (2000) 1.52
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology (2004) 1.49
Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol (1998) 1.45
Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44
Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem (1998) 1.43
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol (1990) 1.41
Alteration of the serotonergic nervous system in fatal familial insomnia. Ann Neurol (2000) 1.41
Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1988) 1.40
A unique case of cerebral spleen. Am J Surg Pathol (1998) 1.39
Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey. Neurology (2003) 1.37
Myoclonic epilepsy with lafora bodies. Some ultrastructural, histochemical, and biochemical aspects. Arch Neurol (1971) 1.36
Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett (1989) 1.35
Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet (1988) 1.33
Aberrant metal binding by prion protein in human prion disease. J Neurochem (2001) 1.33
Immunocytochemical properties of Alzheimer straight filaments. J Neurosci (1987) 1.32
Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol (1987) 1.32
Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A (2000) 1.31
Nervous system in Pompe's disease. Ultrastructure and biochemistry. J Neuropathol Exp Neurol (1971) 1.31
Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J Neurochem (2001) 1.30
The present and the future of neuroimaging in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2010) 1.30
Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J Biol Chem (1999) 1.30
Motor neuron disease in the province of Turin, Italy, 1966-1980. Survival analysis in an unselected population. J Neurol Sci (1985) 1.29
The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem (2000) 1.29
Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology (1992) 1.29
Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry (2007) 1.28
Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun (1994) 1.27
Spongioblastomas, astrocytomas and Rosenthal fibers. Ultrastructural, tissue culture and enzyme histochemical investigations. Acta Neuropathol (1972) 1.26
Primary intracranial neoplasms of infancy and early childhood. Childs Nerv Syst (1997) 1.26
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci U S A (1991) 1.26
A longitudinal study on quality of life and depression in ALS patient-caregiver couples. Neurology (2007) 1.25
Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. J Biol Chem (1997) 1.24
Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol (1990) 1.23
Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med (1997) 1.23
Congenital immature teratoma of the fetal brain. Childs Nerv Syst (1997) 1.22
Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. Proc Natl Acad Sci U S A (1998) 1.22
Neuronal and astrocytic differentiation in human neuroepithelial neoplasms. An immunohistochemical study. J Neuropathol Exp Neurol (1983) 1.21
Aluminum effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci (1984) 1.21
Accessibility of a critical prion protein region involved in strain recognition and its implications for the early detection of prions. Cell Mol Life Sci (2008) 1.20
Puromycin: action on neuronal mitochondria. Science (1968) 1.20
Reorganization of axoplasmic organelles following beta, beta'-iminodipropionitrile administration. J Cell Biol (1981) 1.19
Glial fibrillary acidic protein (GFAP) in ependymal cells during development. An immunocytochemical study. Brain Res (1980) 1.19
A new type of late infantile amaurotic idiocy. The fine structure of the multilamellar cytosome. J Neuropathol Exp Neurol (1968) 1.18
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol (2001) 1.18
Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol (2001) 1.18
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. Ann Neurol (1988) 1.17
Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem (1996) 1.16
Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci (2003) 1.15
Hirano bodies contain tau protein. Brain Res (1987) 1.14
Pathological reaction of astrocytes in perinatal brain injury. Immunohistochemical study. Acta Neuropathol (1986) 1.13